Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Sensydia has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in June 2023.
Sensydia's investors include Colle Capital Partners, Frontier Venture Capital, National Heart, Lung and Blood Institute, Orlando Health Ventures.
Sensydia is headquartered in Los Angeles, United States.
Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Sensydia is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sensydia — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/sensydia. Accessed August 14, 2026.
VCBacked. (2023). Sensydia — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sensydia
{{cite web |title=Sensydia — Funding & Investors |url=https://www.vcbacked.co/company/sensydia |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated